Delivery Order SPE2DR25D2007-SPE2DR26FM07V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,266.52 to AmerisourceBergen Drug Corp for the supply of Acamprosate Calcium 333 mg tablets (180-count) with a completion deadline of September 12, 2025. This is a firm fixed price, non-competitive delivery order issued under a child contract arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,217.28 delivery order is for 180 tablets of acamprosate calcium delayed-release 333 mg, a medication used to treat alcohol dependence. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- Amerisourcebergen Drug Corp has received a $28,721.98 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 180 count bottles of Acamprosate Calcium 333 mg tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with completion by February 23, 2022. As a leading pharmaceutical distributor, Amerisourcebergen Drug Corp regularly obtains delivery orders to supply medications and medical supplies to DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,064.52 firm fixed-price delivery order is for ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award, with the ID SPE2DB22D3016|SPE2DB25FALW9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567113106 - ACAMPROSATE CALC DR 333 MG TAB 180S, with a ceiling value of $1,064.52 and a completion date of February 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,207.06 to AmerisourceBergen Drug Corp for 30 tablets of Disulfiram 250 mg, with an ultimate completion date of November 7, 2025. This competitive award, issued on November 6, 2025, utilizes firm fixed pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Acetazolamide ER 500 mg capsules (60-count units) under a firm fixed-price contract valued at $2,108.53. The order, which is expected to be completed by June 20, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Acetazolamide ER 500 mg, valued at $1,355.22. The award was made on July 14, 2025, with a completion deadline of July 15, 2025. This is a firm fixed-price, non-set-aside delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,713.71 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Disulfiram 250 mg, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM07VDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Acamprosate Calcium 333 mg tablets (180 count) valued at $1,064.52. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. Acamprosate, a medication used in the treatment of alcohol use disorder, represents one of the diverse therapeutic categories within the company's federal pharmaceutical distribution portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/4/25 |